Reposted from the WeChat official account “Tianxia Chushang”: [Chushang Updates] The first delegation of the Chushang ASEAN Tour paid a visit to Wansongtang Health Group.
Release time：2025-03-20
Page Views:
[Reprint Notice] This article is reprinted from the WeChat official account “Tianxia Chushang.” The original title is “[Chushang Updates]: The Delegation of the First Chushang ASEAN Tour Visits Wansongtang Health Group,” published on March 12, 2025. The original article can be found at: https://mp.weixin.qq.com/s/41akrKuY2CbJv3Edz3iByQ
The original text is as follows:
On March 11, members of the inaugural Chu Shang ASEAN Delegation visited Wansongtang Health Group and held a roundtable discussion. Attending the exchange were Cheng Botao and Wu Yao, Deputy Secretaries-General of the Hubei Chu Shang Federation; Mei Yong, Chairman of Hubei United Light Industry Design & Engineering Co., Ltd.; Zhang Wanjun, Chairman of Wuhan Zhongchuang Tianxia; Liu Jun, General Manager of Hubei Sian Pharmaceutical Co., Ltd.; Li Jingjing, General Manager of Wuhan Yingqi Display Design & Engineering Co., Ltd.; Jiang Zebing, Deputy General Manager of Sales at Hubei Dongming Pharmaceutical Co., Ltd.; and Chen Lifen, Chairwoman of Wuhan Lifen Tourism & Exhibition Co., Ltd. The delegation was accompanied throughout by senior executives, including Shen Xianli, Chairman of Wansongtang Greater Health Pharmaceutical Group, and Shen Wei, Marketing Director of the Wuhan branch.
At the symposium, Shen Xianli shared the company’s 30-year development journey and its international expansion strategy: Over its first three decades, the company capitalized on the early‑stage internet boom in its first ten years and, in the past five years, leveraged the booming health‑care sector to achieve explosive growth in overseas trade. Since first engaging with international trade in 2014, the company identified opportunities for Chinese herbal products in African markets in 2016, and by 2020 had deepened its presence across Africa by tapping into resources from overseas Chinese associations. By 2024, overseas sales accounted for more than 80% of total revenue, with industrial operations now established in Kenya, Ghana, and Nigeria.
“In the future, I will put the ‘Three-Hundred Plan’ into practice—running a hundred marathons, building a century-old enterprise, and decoding the genetic profiles of a hundred long-lived individuals—so that the health industry and culture can advance in tandem,” emphasized Shen Xianli. Regarding the upgrade of Wansongtang’s product portfolio, Mei Yong, Chairman of Hubei United Light Industry Design Engineering Co., Ltd., offered the following recommendation: With China’s tea‑drink market exceeding RMB 100 billion in size, he suggested transforming existing herbal powder formulations into ready‑to‑drink tea‑infusion beverages, piloting 5 to 10 best‑selling products, co‑creating a new “health‑focused tea drink” category with B‑to‑B channels, and tailoring formulations to meet region‑specific health needs.
This visit, an important continuation of the Chu Business ASEAN Tour, builds on the strong bonds forged during the earlier ASEAN initiative. Participating delegates eagerly signed up to take part in this roundtable discussion. Throughout the exchange, attendees engaged enthusiastically, sharing their perspectives and working together to create a new ecosystem for the health industry’s global expansion, thereby fostering broader cooperation and development of the greater health sector in international markets.
Overview of Wansongtang Health Group
Founded in 1996, Wansongtang Health Group is a high-tech enterprise group specializing in the research and development, production and processing, marketing and promotion, as well as personalized, professional customization services for a comprehensive range of health products, including wellness teas, meal-replacement powders, solid beverages, convenience foods, health supplements, novel‑resource foods, specialized dietary and medical foods, and medical devices.
Wansongtang adheres to an operational model that integrates “independent branding plus OEM,” “internal consumption plus external application,” “products plus services,” “online plus offline channels,” and “domestic sales plus international trade.” Its sales network spans 28 provinces, municipalities, and autonomous regions across China, with products exported to more than 20 countries and regions in Europe, the Americas, the Middle East, Africa, and Southeast Asia.
In the past, Wansongtang has successfully transformed and upgraded itself from a health‑focused enterprise into a full‑fledged health industry player. Looking ahead, Wansongtang will dedicate itself to building a “Greater Health+” ecosystem, continuing its remarkable evolution from the health industry to a broader health‑driven mission. As we enter a new era, Wansongtang will embrace an even more open and inclusive mindset, adopt iterative, innovation‑driven thinking, and pursue pragmatic, science‑based actions. Together with global partners, we will lead the way in promoting healthy lifestyles, co‑create wealth through health, and contribute Wansongtang’s wisdom, philosophy, and sense of responsibility to the advancement and development of human health.
